31 /100
MEDIUM RISK
Score updated May 16, 2026

CRVS — Corvus Pharmaceuticals, Inc. Dilution Risk Tracker

Track CRVS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CRVS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
50
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
13%
💰 Capital Raise 18%
• Active ATM program with $200M remaining capacity
📜 Warrant Exercise 15%
• Warrant overhang: 10.6% of shares outstanding
🔔 Track CRVS — Get forecast alerts →

💹 Market Data

Market Cap$1.04B
Shares Outstanding84.09M
Float71.34M
Cash$236.71M
Debt$834.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 15.2% shares (2025Q4 vs prior)
126 institutional holders · 48.72M shares
#1 ORBIMED ADVISORS LLC 7.17M shares
#2 BlackRock, Inc. 5.06M shares
#3 VANGUARD GROUP INC 3.87M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest18.39M
Days to Cover11.5
% of Float25.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
8-K 8K EVENT Apr 23, 2026
8-K 8K EVENT Mar 13, 2026
424B5 ATM Mar 13, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track CRVS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CRVS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: AGCC AGH AIP ALLO AMLX
🔬 More Research for CRVS
📊 CRVS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CRVS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.